FT App on Android & iOS
CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
，推荐阅读TG官网-TG下载获取更多信息
fn init_tracer_provider() - SdkTracerProvider {
Nichicon 1000μF Electrolytic Capacitor 25V